Search results: Sage Journals

Free accessResearch articleFirst published August, 2018

Application of High-Throughput Flow Cytometry in Early Drug Discovery: An AstraZeneca Perspective

Mei Ding, Roger Clark, Catherine Bardelle [...]

Journal of Biomolecular Screening

Restricted accessCase reportFirst published September, 2023

Branch retinal vein occlusion following ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine

Georgia Karageorgiou, Konstantina Chronopoulou, Ilias Georgalas [...]

European Journal of Ophthalmology

Free accessOtherFirst published April, 2005

Compound Management and Enhancement Activities in AstraZeneca

Judith Provis

Journal of Laboratory Automation

Restricted accessResearch articleFirst published December, 2022

Analysis of collaboration between AstraZeneca and the higher education sector in the UK

Asma Rezaei, Ali Reza Kamali

Industry and Higher Education

Open accessResearch articleFirst published February, 2024

ABO blood group associated with cerebral venous thrombosis after Oxford-AstraZeneca COVID-19 vaccination: a case–control study

Gie Ken-Dror, Pankaj Sharma, on behalf of the international Bio-Repository to Establish the Aetiology of Sinovenous Thrombosis (BEAST) collaborators and Cerebral Venous Sinus Thrombosis With Thrombocytopenia Syndrome Study Group

Journal of the Royal Society of Medicine

Free accessOtherFirst published October, 2008

The Race for Data: Compound Distribution at AstraZeneca R&D Boston

Karen Hvezda, Matthew Boeckeler

Journal of Laboratory Automation

Open accessCase reportFirst published 2024

New-onset cutaneous lichen planus following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination

Amira Muftah, Stephen Lee, Mariam Abbas

Sage Open Medical Case Reports

Open accessCase reportFirst published 2023

Cerebral venous sinus thrombosis following ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine

Shyam S Sharma, Giosue Gulli, Pankaj Sharma

JRSM Cardiovascular Disease

Open accessCase reportFirst published 2022

Chronic Spontaneous Urticaria Triggered by the AstraZeneca/Oxford COVID-19 Vaccine with Achieved Remission: A Case Report

Stephanie G Brooks, Anna M De Jong, Mina Abbaslou [...]

Therapeutic Advances in Allergy and Rhinology

Restricted accessResearch articleFirst published December 1, 1998

AstraZeneca and Breast Cancer Advocacy

Karen Miller

Breast Disease

Free accessResearch articleFirst published August, 2018

Application of High-Throughput Flow Cytometry in Early Drug Discovery: An AstraZeneca Perspective

Mei Ding, Roger Clark, Catherine Bardelle [...]

Journal of Biomolecular Screening

Restricted accessCase reportFirst published September, 2023

Branch retinal vein occlusion following ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine

Georgia Karageorgiou, Konstantina Chronopoulou, Ilias Georgalas [...]

European Journal of Ophthalmology

Free accessOtherFirst published April, 2005

Compound Management and Enhancement Activities in AstraZeneca

Judith Provis

Journal of Laboratory Automation

Restricted accessResearch articleFirst published December, 2022

Analysis of collaboration between AstraZeneca and the higher education sector in the UK

Asma Rezaei, Ali Reza Kamali

Industry and Higher Education

Open accessResearch articleFirst published February, 2024

ABO blood group associated with cerebral venous thrombosis after Oxford-AstraZeneca COVID-19 vaccination: a case–control study

Journal of the Royal Society of Medicine

Free accessOtherFirst published October, 2008

The Race for Data: Compound Distribution at AstraZeneca R&D Boston

Karen Hvezda, Matthew Boeckeler

Journal of Laboratory Automation

Open accessCase reportFirst published 2024

New-onset cutaneous lichen planus following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination

Amira Muftah, Stephen Lee, Mariam Abbas

Sage Open Medical Case Reports

Open accessCase reportFirst published 2023

Cerebral venous sinus thrombosis following ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine

Shyam S Sharma, Giosue Gulli, Pankaj Sharma

JRSM Cardiovascular Disease

Open accessCase reportFirst published 2022

Chronic Spontaneous Urticaria Triggered by the AstraZeneca/Oxford COVID-19 Vaccine with Achieved Remission: A Case Report

Stephanie G Brooks, Anna M De Jong, Mina Abbaslou [...]

Therapeutic Advances in Allergy and Rhinology

Restricted accessResearch articleFirst published December 1, 1998

AstraZeneca and Breast Cancer Advocacy

Karen Miller

Breast Disease